Intuitive Surgical reported Q1 2026 revenue $2.77 bn and EPS $2.50, beating analyst forecasts of $2.62 bn and $2.12 per share.
Gross margin rose to 67.8% versus the expected 66.1%, and worldwide da Vinci and Ion procedures grew about 17% YoY.
The company placed 431 da Vinci systems, expanding its installed base to 11,395 units, and raised FY2026 procedure growth outlook to 13.5‑15.5%.
Shares jumped 2.4% pre‑market, while Jefferies cut the price target to $515 from $560 amid expectations of moderated growth.